Glaub Kathleen Sereda 4
4 · IO Biotech, Inc. · Filed May 31, 2022
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Glaub Kathleen Sereda
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-05-26+23,885→ 23,885 totalExercise: $4.85Exp: 2032-05-26→ Common Stock (23,885 underlying)
Footnotes (1)
- [F1]These options vest on May 26, 2023, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.